Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire.

Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR and MDS Non-motor PD Study Group.

Eur J Neurol. 2018 Oct;25(10):1255-1261. doi: 10.1111/ene.13691. Epub 2018 Jun 22.

PMID:
29806962
2.

Tracking Parkinson's: Study Design and Baseline Patient Data.

Malek N, Swallow DM, Grosset KA, Lawton MA, Marrinan SL, Lehn AC, Bresner C, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG; PRoBaND.

J Parkinsons Dis. 2015;5(4):947-59. doi: 10.3233/JPD-150662.

3.

King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.

Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P; EUROPAR and the IPMDS Non Motor PD Study Group.

Mov Disord. 2015 Oct;30(12):1623-31. doi: 10.1002/mds.26270. Epub 2015 Jun 11.

PMID:
26096067
4.

The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.

Massey LA, Jäger HR, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton J, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Micallef C.

Neurology. 2013 May 14;80(20):1856-61. doi: 10.1212/WNL.0b013e318292a2d2. Epub 2013 Apr 24.

5.

Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.

Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jäger HR.

Mov Disord. 2012 Dec;27(14):1754-62. doi: 10.1002/mds.24968. Epub 2012 Apr 4.

PMID:
22488922
6.

Difference in MSA phenotype distribution between populations: genetics or environment?

Ozawa T, Revesz T, Paviour D, Lees AJ, Quinn N, Tada M, Kakita A, Onodera O, Wakabayashi K, Takahashi H, Nishizawa M, Holton JL.

J Parkinsons Dis. 2012;2(1):7-18. doi: 10.3233/JPD-2012-11056. Review.

PMID:
23939403
7.

PINK1: pumps, paraesthesia, punding and psychosis.

Paviour DC, Marion MH.

J Neurol. 2012 Jun;259(6):1241-2. doi: 10.1007/s00415-011-6327-z. Epub 2011 Nov 30. No abstract available.

PMID:
22127616
8.

The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

McCrone P, Payan CA, Knapp M, Ludolph A, Agid Y, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(9):e24369. doi: 10.1371/journal.pone.0024369. Epub 2011 Sep 8.

9.

Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.

Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph AC, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(8):e22293. doi: 10.1371/journal.pone.0022293. Epub 2011 Aug 4.

10.

A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability.

Rolland Y, Vérin M, Payan CA, Duchesne S, Kraft E, Hauser TK, Jarosz J, Deasy N, Defevbre L, Delmaire C, Dormont D, Ludolph AC, Bensimon G, Leigh PN; NNIPPS Study Group.

J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):1025-32. doi: 10.1136/jnnp.2010.214890. Epub 2011 Mar 8.

11.

Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome.

Rohrer JD, Paviour D, Vandrovcova J, Hodges J, de Silva R, Rossor MN.

Neurodegener Dis. 2011;8(3):149-52. doi: 10.1159/000319454. Epub 2010 Sep 14.

12.

Juvenile levodopa-responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment.

Espay AJ, Paviour DC, O'Sullivan JD, Schmidt RE, Revilla FJ, Metman LV.

Mov Disord. 2010 Sep 15;25(12):1860-7. doi: 10.1002/mds.23194.

PMID:
20669183
13.

Does corticobasal degeneration exist? A clinicopathological re-evaluation.

Ling H, O'Sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, Paviour DC, Lees AJ.

Brain. 2010 Jul;133(Pt 7):2045-57. doi: 10.1093/brain/awq123.

PMID:
20584946
14.

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS Study Group.

Brain. 2010 Aug;133(Pt 8):2382-93. doi: 10.1093/brain/awq158. Epub 2010 Jun 24.

PMID:
20576697
15.

Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis.

Rohrer JD, Paviour D, Bronstein AM, O'Sullivan SS, Lees A, Warren JD.

Mov Disord. 2010 Jan 30;25(2):179-188. doi: 10.1002/mds.22946.

16.

Nutritional optic and peripheral neuropathy: a case report.

Nightingale LM, Paviour DC.

Cases J. 2009 Jun 5;2:7762. doi: 10.4076/1757-1626-2-7762.

17.

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.

Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, Kretzschmar H, Lang AE, Litvan I, Lucas JJ, McGeer PL, Melquist S, Oertel W, Otto M, Paviour D, Reum T, Saint-Raymond A, Steele JC, Tolnay M, Tumani H, van Swieten JC, Vanier MT, Vonsattel JP, Wagner S, Wszolek ZK; Reisensburg Working Group for Tauopathies With Parkinsonism.

Eur J Neurol. 2009 Mar;16(3):297-309. doi: 10.1111/j.1468-1331.2008.02513.x. Review.

18.

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group.

Brain. 2009 Jan;132(Pt 1):156-71. doi: 10.1093/brain/awn291. Epub 2008 Nov 23.

19.

Paroxysmal hemicrania and POEMS syndrome: further evidence that neuropeptides are implicated in primary headache?

Paviour DC, Ellis CM.

Cephalalgia. 2008 Nov;28(11):1204-6. doi: 10.1111/j.1468-2982.2008.01669.x. Epub 2008 Jul 15. No abstract available.

PMID:
18644027
20.

Chiari-1 malformation and the neck-tongue syndrome: cause or coincidence?

Wong SL, Paviour DC, Clifford-Jones RE.

Cephalalgia. 2008 Sep;28(9):994-5. doi: 10.1111/j.1468-2982.2008.01625.x. Epub 2008 Jun 28. No abstract available.

PMID:
18557983

Supplemental Content

Loading ...
Support Center